110 related articles for article (PubMed ID: 37551038)
1. Paracetamol use and risk of epithelial ovarian cancer: A nationwide nested case-control study.
Zheng G; Faber MT; Baandrup L; Kjaer SK
BJOG; 2024 Feb; 131(3):290-299. PubMed ID: 37551038
[TBL] [Abstract][Full Text] [Related]
2. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
3. Prescription use of paracetamol and risk for ovarian cancer in Denmark.
Baandrup L; Friis S; Dehlendorff C; Andersen KK; Olsen JH; Kjaer SK
J Natl Cancer Inst; 2014 Jun; 106(6):dju111. PubMed ID: 24848623
[TBL] [Abstract][Full Text] [Related]
4. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
[TBL] [Abstract][Full Text] [Related]
5. Antihistamine use and risk of ovarian cancer: A population-based case-control study.
Verdoodt F; Pottegård A; Dehlendorff C; Jäättelä M; Hallas J; Friis S; Kjaer SK
Maturitas; 2019 Feb; 120():47-52. PubMed ID: 30583764
[TBL] [Abstract][Full Text] [Related]
6. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant use and ovarian cancer risk: Evidence from nationwide studies with >14,000 cases from Denmark and Sweden.
Zheng G; Baandrup L; Wang J; Hertzum-Larsen R; Hannibal CG; Mørch LS; Faber MT; Sundström K; Kjær SK
Maturitas; 2024 Jul; 185():108009. PubMed ID: 38688107
[TBL] [Abstract][Full Text] [Related]
8. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
9. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Läärä E; Hinkula M
BJOG; 2018 Jul; 125(8):1001-1008. PubMed ID: 29412502
[TBL] [Abstract][Full Text] [Related]
10. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
[TBL] [Abstract][Full Text] [Related]
12. Use of paracetamol, low-dose aspirin, or non-aspirin non-steroidal anti-inflammatory drugs and risk of ovarian borderline tumors in Denmark.
Hannibal CG; Dehlendorff C; Kjaer SK
Gynecol Oncol; 2018 Dec; 151(3):513-518. PubMed ID: 30249529
[TBL] [Abstract][Full Text] [Related]
13. Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy.
Ring LL; Baandrup L; Zheng G; Gottschau M; Dehlendorff C; Mellemkjær L; Kjaer SK
Cancer Epidemiol; 2023 Jun; 84():102359. PubMed ID: 37054550
[TBL] [Abstract][Full Text] [Related]
14. Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES).
Staples JN; Peres LC; Camacho F; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy ML; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Schildkraut JM
Gynecol Oncol; 2020 Jul; 158(1):123-129. PubMed ID: 32362566
[TBL] [Abstract][Full Text] [Related]
15. Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.
Darelius A; Kristjansdottir B; Dahm-Kähler P; Strandell A
Int J Cancer; 2021 Oct; 149(8):1544-1552. PubMed ID: 34152012
[TBL] [Abstract][Full Text] [Related]
16. Sexually Transmitted Infections and Risk of Epithelial Ovarian Cancer: Results From the Finnish Maternity Cohort.
Skarga E; Surcel HM; Kaaks R; Waterboer T; Fortner RT
J Infect Dis; 2023 Nov; 228(11):1621-1629. PubMed ID: 37196097
[TBL] [Abstract][Full Text] [Related]
17. Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).
Schildkraut JM; Abbott SE; Alberg AJ; Bandera EV; Barnholtz-Sloan JS; Bondy ML; Cote ML; Funkhouser E; Peres LC; Peters ES; Schwartz AG; Terry P; Crankshaw S; Camacho F; Wang F; Moorman PG
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1411-1417. PubMed ID: 27197282
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy and association with ovarian cancer risk in the New England Case Control (NEC) study.
Akinwunmi B; Vitonis AF; Titus L; Terry KL; Cramer DW
Int J Cancer; 2019 Mar; 144(5):991-1000. PubMed ID: 30006925
[TBL] [Abstract][Full Text] [Related]
19. Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma.
Lessard-Anderson CR; Handlogten KS; Molitor RJ; Dowdy SC; Cliby WA; Weaver AL; Sauver JS; Bakkum-Gamez JN
Gynecol Oncol; 2014 Dec; 135(3):423-7. PubMed ID: 25316178
[TBL] [Abstract][Full Text] [Related]
20. Statin use and risk for ovarian cancer: a Danish nationwide case-control study.
Baandrup L; Dehlendorff C; Friis S; Olsen JH; Kjær SK
Br J Cancer; 2015 Jan; 112(1):157-61. PubMed ID: 25393364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
